2010
DOI: 10.1016/j.biomaterials.2010.05.060
|View full text |Cite
|
Sign up to set email alerts
|

Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
33
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
8
1

Relationship

6
3

Authors

Journals

citations
Cited by 58 publications
(34 citation statements)
references
References 50 publications
(62 reference statements)
1
33
0
Order By: Relevance
“…[40][41][42] Moreover, certain technological approaches could endow these nanoplexes with selective targeting properties against specific tumors, further improving their biodistribution and increasing the pharmacological action of the encapsulated drug(s). 43 Finally, synergic action with conventional antitumor compounds could be the source of a new multidrug nanomedicine able to decrease the IC 50 of single drugs and therefore their side effects. …”
Section: Resultsmentioning
confidence: 99%
“…[40][41][42] Moreover, certain technological approaches could endow these nanoplexes with selective targeting properties against specific tumors, further improving their biodistribution and increasing the pharmacological action of the encapsulated drug(s). 43 Finally, synergic action with conventional antitumor compounds could be the source of a new multidrug nanomedicine able to decrease the IC 50 of single drugs and therefore their side effects. …”
Section: Resultsmentioning
confidence: 99%
“…This practice has opened up new opportunities in the field of pharmaceutical research and the design of novel polymer-based nanoparticles has been reported extensively in the literature [22][23][24][25][26][27]. Polyethylene glycol (PEG) is the most commonly used polymer in clinical practice [28].…”
Section: Introductionmentioning
confidence: 99%
“…To improve selectivity and efficacy towards tumor cells, the first strategy is to design active targeting nanoparticles modified by targeting moieties such as nucleic acids [5,6], antibodies [7,8] and various ligands [9][10][11]. As drug-delivery agents, these multifunctional nano-carriers are capable of targeting cancer cells, delivering and releasing drugs in a regulated manner, and detecting cancer cells with enormous specificity and sensitivity.…”
Section: Introductionmentioning
confidence: 99%